The estimated Net Worth of David L Kemmerly is at least 6.71 百万$ dollars as of 29 March 2022. Mr. Kemmerly owns over 2,500 units of Amedisys stock worth over 1,580,018$ and over the last 8 years he sold AMED stock worth over 3,272,531$. In addition, he makes 1,862,160$ as Chief Legal and Government Affairs Officer at Amedisys.
Sign up
Mr. Kemmerly AMED stock SEC Form 4 insiders trading
David has made over 24 trades of the Amedisys stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 2,500 units of AMED stock worth 443,275$ on 29 March 2022.
The largest trade he's ever made was exercising 23,437 units of Amedisys stock on 5 May 2020 worth over 641,002$. On average, David trades about 3,698 units every 71 days since 2016. As of 29 March 2022 he still owns at least 16,336 units of Amedisys stock.
You can see the complete history of Mr. Kemmerly stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Kemmerly biography
David L. Kemmerly serves as Chief Legal and Government Affairs Officer of the Company. He previously served as General Counsel from October 2015 to March 2020 and Senior Vice President, Government Affairs from March 2015 to March 2020. He previously served as Interim General Counsel from March 30, 2015 to October 30, 2015. Mr. Kemmerly has over 27 years of experience in governmental affairs, with more than 19 years specializing in health care law and public policy. From September 2013 to March 2015, he served as Special Counsel at Adams and Reese LLP, a multidisciplinary law firm where he represented diverse health care interests before the state legislature and state agencies. Prior to Adams and Reese, Mr. Kemmerly served as Director of State Public Affairs of Humana, Inc. for six years where he was responsible for legislative and regulatory affairs and outcomes in all 50 states. In this role, he developed and led implementation of successful state legislative and regulatory strategies that helped protect the business interests of one of the nation’s largest health insurers with over 13 million medical enrollees. Mr. Kemmerly has extensive experience in state and national government relations, including serving as Associate Director of the Department of Government Affairs for the Louisiana State Medical Society where he lobbied state legislators, state regulatory agencies, and the U.S. Congress on issues impacting physicians and the practice of medicine. He also served as an attorney for the Louisiana State Senate, a political consultant for DLK Consulting Group, and on the staffs of a Governor and Member of Congress. Mr. Kemmerly is a member of the Board of the Amedisys Foundation (since March 2016).
What is the salary of David Kemmerly?
As the Chief Legal and Government Affairs Officer of Amedisys, the total compensation of David Kemmerly at Amedisys is 1,862,160$. There are 4 executives at Amedisys getting paid more, with Paul Kusserow having the highest compensation of 12,835,500$.
How old is David Kemmerly?
David Kemmerly is 57, he's been the Chief Legal and Government Affairs Officer of Amedisys since 2020. There are 10 older and 10 younger executives at Amedisys. The oldest executive at Amedisys Inc. is Molly Coye, 72, who is the Independent Director.
What's David Kemmerly's mailing address?
David's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.
Insiders trading at Amedisys
Over the last 27 years, insiders at Amedisys have traded over 269,564,877$ worth of Amedisys stock and bought 2,690,968 units worth 38,198,016$ . The most active insiders traders include Asset Management Llc Kohlbe...、Tide Capital, Llc North Tid...、David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of 2,494,602$. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth 896,937$.
What does Amedisys do?
amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i
What does Amedisys's logo look like?
Complete history of Mr. Kemmerly stock trades at Amedisys
Amedisys executives and stock owners
Amedisys executives and other stock owners filed with the SEC include:
-
Paul Kusserow,
Chairman of the Board, President, Chief Executive Officer -
Christopher Gerard,
Chief Operating Officer -
Scott Ginn,
Chief Financial Officer -
Sharon Brunecz,
Chief Human Resource Officer -
David Kemmerly,
Chief Legal and Government Affairs Officer -
Paul Berthold Kusserow,
Chairman & CEO -
Michael North,
Chief Information Officer -
Christopher T. Gerard,
Pres, COO & Director -
Scott G. Ginn,
Exec. VP & CFO -
David L. Kemmerly,
Chief Legal & Gov. Affairs Officer -
Sharon Brunecz,
Chief HR Officer -
Julie Klapstein,
Independent Director -
Richard Lechleiter,
Lead Independent Director -
Bruce Perkins,
Independent Director -
Jeffrey Rideout,
Independent Director -
Teresa Kline,
Independent Director -
Molly Coye,
Independent Director -
Vickie Capps,
Independent Director -
Nick Muscato,
Vice President of Strategic Finance -
Denise Bohnert,
Chief Compliance Officer -
Janet Britt,
Sr. VP of Billing & Collections -
Adam Holton,
Chief People Officer -
Jennifer Guckert Griffin,
Sr. VP, Deputy Gen. Counsel, Corp. Sec. & Interim Chief Legal Officer -
John Nugent,
Chief Acquisitions Officer -
Kendra Kimmons,
VP of Marketing & Communications -
Denise Bohnert,
Chief Compliance Officer -
Michael P. North,
Chief Information Officer -
Pete Hartley,
CTO & Sr. VP of Bus. Operations Systems -
Jake L Netterville,
Director -
Jeffrey D Jeter,
Chief Compliance Officer -
Donald A Washburn,
Director -
Nathaniel M Zilkha,
Director -
David B. Pearce,
Chief Compliance Officer -
Lawrence R Pernosky,
Chief Human Resources Officer -
Martin B Howard,
Chief Information Officer -
Ronald A Laborde,
Director -
Stephen Seim,
Chief Strategy Officer -
Gary D Willis,
Chief Financial Officer -
Linda J. Hall,
Director -
Jane Carmody,
See Remarks -
Daniel P Mc Coy,
Chief Operating Officer -
Alice A Schwartz,
CIO -
Susan Sender,
See Remarks -
Asset Management Llc Kohlbe...,
-
Allyson Guidroz,
Chief Accounting Officer -
Richard M Ashworth,
President and CEO -
Larry R Graham,
COO -
Donald Jr Loverich,
Principal Accounting Officer -
John F Giblin,
Chief Financial Officer -
Gregory H Browne,
Chief Financial Officer -
David Nierenberg,
10% owner -
John Hank Linden,
Chief Information Officer -
Listed Ltd Terra,
10% owner -
Tide Capital, Llc North Tid...,
-
Peter Ricchiuti,
Director -
Michael O. Fleming,
Chief Medical Officer -
David R Bucey,
General Counsel and Secretary -
David R Pitts,
Director -
William F Borne,
CEO -
T A Jr Barfield,
Chief Development Officer -
Dale E Redman,
Chief Financial Officer -
Michael D Snow,
Chief Operating Officer -
Ivanetta Davis Samuels,
Director -
Adam Y Holton,
Chief People Officer